Diagnos Inc V.ADK

Alternate Symbol(s): DGNOF

Technology Information Technology Services

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.

TSXV:ADK - Post by User

Diagnos Inc

Bullboard Posts

Comment by u2bobon Jan 14, 2019 3:19pm

122 Views

Post# 29229475

RE:RE:RE:RE:RE:This article was published on the 20/20 Now Linkedin feed

ARIMA11 wrote: Agreed Luckshmuck. Its almost deliberate. Its cheap options and a way for GMP to accumulate. Frustrating for retail nonetheless because management does not care about the share price.

Its a long long game. However, GMP is key here.They will decide what goes, when and how.
For now its watching the paint dry. Opportunity cost? Yes but will give it some more time.
If GMP was not there it would be a different story.

TRUE AND TRUE !